John L. Cameron*

John L. Cameron*

Departments Of Oncology (Drs Cunningham, Iacobuzio-Donahue, Kern, And Yeo), Pathology (Drs Iacobuzio-Donahue, Maitra, Ashfaq, And Montgomery), And Surgery (Drs Heitmiller, ...

Direct Impact

Concepts for which John L Cameron* has direct influence:

pancreatic cancer
acute pancreatitis
surgical resection
johns hopkins
adjuvant therapy
periampullary adenocarcinoma
bile duct

External impact

Concepts related to the work of other authors for which John L Cameron* has influence:

airway management
apneic oxygénation
nasal canula
oxygenation flow
groups compared
infants trial
anaesthesia desaturation

Prominent publications by John L. Cameron*

KOL-Index: 94 BackgroundDelayed bleeding after pancreaticoduodenectomy (PD) is a life-threatening complication. However, the optimal management remains unclear. We summarize our experience of the management of delayed bleeding after PD and define the outcomes associated with different types of management. MethodsAll patients who underwent a PD between January 1987 and June 2020 at Johns Hopkins University ...
Known for
Unstable | 12 Days | Clinically Relevant Postoperative Pancreatic | First-Line Approach
KOL-Index: 86 BACKGROUND: Lymphoepithelial cysts (LECs) are rare pancreatic cystic lesions. Since LECs are benign, preoperative diagnosis is important to differentiate from a cystic neoplasm and avoid unnecessary surgery. The aim of this study was to identify clinical, radiographic and cytopathologic features associated with LECs. METHODS: A retrospective review was performed of patients diagnosed with ...
Known for
Cysts Lecs | Lymphoepithelial | Radiographic Imaging | Lec Underwent
KOL-Index: 78
KOL-Index: 68 BACKGROUND: Lymph node (LN) metastasis is associated with decreased survival following resection for pancreatic ductal adenocarcinoma (PDAC). In N0 disease, increasing total evaluated LN (ELN) correlates with improved outcomes suggesting patients may be understaged when LNs are undersampled. We aim to assess the optimal number of examined lymph nodes (ELN) following pancreatectomy. METHODS: ...
Known for
Prognostic Goal | Separate Cutoffs | Accurate Ajcc | Lnr
KOL-Index: 65 BACKGROUND: Periampullary neuroendocrine tumors (NETs) arise from the duodenum, ampulla, and periampullary pancreas. Duodenal and ampullary NETs are rare and may have distinct biologic behavior from pancreatic NETs (P-NETs). We examined the outcomes of these entities. METHODS: An institutional database was queried for patients undergoing resection for pancreatic head, duodenal, or ampullary ...
Known for
Rfs Survival | P-Net | Current American Joint Committee | Ampullary Pancreatic
KOL-Index: 60 Purpose: The purpose of this study was to report toxicity and long-term survival outcomes of 2 prospective trials evaluating mitomycin C (MMC) with 5-fluorouracil-based adjuvant chemoradiation in resected periampullary adenocarcinoma. Methods and materials: From 1996 to 2002, 119 patients received an adjuvant 4-drug chemotherapy regimen of 5-fluorouracil, leucovorin, MMC, and dipyridamole ...
Known for
Pancreatic 39 Nonpancreatic Periampullary | Cox Proportional Hazards Models | 45-54 Gy | 2 Additional Cycles
KOL-Index: 52 Primary pancreatic small cell carcinoma (SCC) is rare, with just over 30 cases reported in the literature. Only 7 of these patients underwent surgical resection with a median survival of 6 months. Prognosis of SCC is therefore considered to be poor, and the role of adjuvant therapy is uncertain. Here we report two institutions' experience with resectable pancreatic SCC. Six patients with ...
Known for
Radiation Cisplatin | Role Combined | Prognosis Scc | Rare Reported
KOL-Index: 51 VIPomas are rare pancreatic endocrine tumors associated with a well-defined clinical syndrome characterized by watery diarrhea, hypokalemia, and metabolic acidosis. The objective of this study was to review a single institution’s experience with VIPomas, as well as to review the English literature. A retrospective review of the Johns Hopkins pancreatic database revealed four cases of VIPoma, ...
Known for
Tumor Tumors | Symptoms Surgical | Revealed Primary | Pancreas Computed
KOL-Index: 48 BACKGROUND: The incidence of occult metastatic disease (OMD) in pancreatic ductal adenocarcinoma (PDAC) and associated risk factors are largely unknown. METHODS: We identified all patients with PDAC, who had an aborted oncologic operation due to OMD within a 10-year period. The cases were matched to a cohort of resected PDAC patients on a 1:3 ratio, based on age and sex, for comparison of ...
Known for
Preoperative Computed Tomography | Aborted Oncologic Operation | Pancreatic Ductal Adenocarcinoma | 13 Ratio
KOL-Index: 43 BACKGROUND: The outcomes of sporadic pancreatic ductal adenocarcinoma (PDAC) patients with germline mutations of BRCA1/BRCA2 remains unclear. The prognostic significance of BRCA1/BRCA2 mutations on survival is not well established. STUDY DESIGN: We performed targeted next-generation sequencing (NGS) to identify BRCA1/BRCA2 germline mutations in resected sporadic PDAC cases from 2000 to 2015. ...
Known for
Brca2 Wild | Institutional Database | Mutation Sporadic | Alternative Chemotherapy

Departments of Oncology (Drs Cunningham, Iacobuzio-Donahue, Kern, and Yeo), Pathology (Drs Iacobuzio-Donahue, Maitra, Ashfaq, and Montgomery), and Surgery (Drs Heitmiller, Choti, Lillemoe, Cameron, Yeo, and Schulick)

© 2022 - Key Opinion Leaders -
Key Opinion Leaders, LLC ,
2025 NW 102 Avenue, Suite 111 Doral , FL   33172